Lockbox LIMS
A cloud-based Laboratory Information Management System (LIMS) is designed to oversee sample tracking, test outcomes, and inventory management specifically for life sciences research, industrial quality control laboratories, and biotechnology/next-generation sequencing applications. This comprehensive system provides essential regulatory compliance support for standards such as CLIA, HIPAA, Part 11, and ISO 17025, ensuring that laboratories operate within the necessary legal frameworks. The importance of quality, security, and traceability in managing samples cannot be overstated, as these factors play a pivotal role in a lab's effectiveness and reliability. Utilizing the Lockbox LIMS platform, laboratory professionals gain the ability to meticulously oversee their samples, offering complete transparency throughout the entire process, from initial accession to long-term preservation. Additionally, LIMS analysis encompasses far more than merely tracking outcomes; the Lockbox system features advanced multilayered sample storage capabilities and location management, allowing users to customize their laboratory's storage framework with diverse options that include rooms, storage units, shelves, racks, and boxes. This flexibility empowers labs to efficiently organize and access their samples, ultimately enhancing operational productivity and accuracy.
Learn more
Venn
Venn is transforming the way organizations manage BYOD workforces by alleviating the challenges associated with purchasing and safeguarding laptops or managing virtual desktops. Their innovative technology offers a fresh perspective on securing remote staff and contractors who utilize unmanaged devices. By utilizing Venn’s Blue Border™ software, businesses can create a company-managed Secure Enclave on the user’s personal computer, which allows IT departments to protect corporate data while respecting the privacy of end users. With over 700 clients, such as Fidelity, Guardian, and Voya, Venn has established itself as a trusted partner in compliance with FINRA, SEC, NAIC, and SOC 2 regulations. Discover more about their solutions at venn.com, where a commitment to enhancing workplace security meets user convenience.
Learn more
Illumina DRAGEN Secondary Analysis
The DRAGEN Secondary Analysis system from Illumina provides accurate, comprehensive, and exceptionally efficient processing of next-generation sequencing data. By leveraging a graph reference genome in combination with machine learning methodologies, it achieves outstanding precision. With a highly streamlined workflow, it can fully analyze a 34x whole human genome in roughly 30 minutes when operated on the DRAGEN server v4. Furthermore, it optimizes this process by reducing FASTQ file sizes by as much as five times. This system is proficient in handling diverse types of NGS data, such as whole genomes, exomes, methylomes, and transcriptomes. It has been designed to work seamlessly with the user's chosen platform and can scale to accommodate various needs. DRAGEN analysis is consistently recognized as a frontrunner in accuracy for detecting both germline and somatic variants, supported by its strong performance in industry competitions hosted by precisionFDA. This sophisticated analytical tool enables laboratories of all sizes and specialties to fully leverage their genomic datasets. Additionally, the integration of highly adaptable field-programmable gate array (FPGA) technology allows DRAGEN to implement hardware-accelerated genomic analysis algorithms, significantly improving its efficiency. These advancements firmly establish DRAGEN as an essential asset in the rapidly advancing realm of genomics, enabling researchers to push the boundaries of scientific discovery.
Learn more
Pluto
Pluto was established in 2021 through the efforts of the Wyss Institute at Harvard University. It has built a reputation as a reliable collaborator for numerous life sciences entities nationwide, including both emerging biotech firms and established biopharmaceutical companies. Their innovative cloud-based platform empowers researchers to effectively organize their data, conduct bioinformatics analyses, and generate high-quality interactive visualizations for publication. This versatile platform finds utility in a diverse range of biological applications, such as research in preclinical and translational sciences, advancements in cell and gene therapies, as well as initiatives in drug discovery and development. Scientists across various fields are leveraging Pluto's capabilities to enhance their research outcomes and drive innovation.
Learn more